Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
New words:
Abbvie, acid, Adaptimmune, adjunct, adult, AE, AEs, AFP, alkylating, Ann, apparently, arena, arming, asin, ASUNo, Atlanta, Aurora, Avastin, BBA, BCMA, begun, Bellicum, bidding, bio, biomarker, BioPharma, biopsy, Biotech, bladder, bribery, brochure, Cadillac, California, CARsgen, caution, cerebrum, certainACA, Chicago, Chiocca, CHIP, circulating, CMC, CMV, codified, cold, communicable, companion, compelling, comprehensive, Concurrently, constraint, content, context, Corrupt, cortex, CRISPR, crucial, cumbersome, curative, David, deadly, debarment, Deferral, DelMar, detention, device, dianhydrogalactitol, diffuse, DIPG, discovered, discovering, dispersed, distinct, distinction, DLBCL, DNATrix, donut, Duke, durvalumab, embezzling, endothelial, enthusiasm, Epidemiology, epithelial, erected, error, excise, Exposition, FC, FCPA, firmly, flat, formarket, foundation, Francisco, frequency, GCP, Gen, geographically, GlaxoSmithKline, GLIADEL, Goldman, greatly, GTP, haploidentical, hole, hot, house, IBC, Immunohistochemistry, improper, improperly, inaccessible, inactive, incomplete, inferred, inflating, input, interleukin, Janssen, Johnson, JPM, Kebriaei, Keystone, KEYTRUDA, kind, Kymriah, Lastly, laundering, Legend, lesion, likelihood, lomustine, loosen, Lurie, Luxturna, lymphocytic, lymphodepleting, lymphodepletion, magnetic, margin, marginal, Mauney, mbIL, mild, minute, mono, mOS, move, Multicenter, Mustang, Nanjing, neck, neurologic, Neurological, nivolumab, noncurrent, nonrefundable, nucleic, obstructing, offense, offshore, oncolytic, OPDIVO, orin, Overview, Partow, passed, PCAOB, PDUFA, pembrolizumab, Pfizer, PHSA, piggyBac, pill, plasmid, political, Poseida, potentialin, PREA, Precigen, precursor, preparatory, prepayment, presence, profound, provisional, PSCA, PVSRIPO, Ratio, reaction, Reauthorization, recommence, repatriated, resonance, resubmit, resubmitted, retroviral, reverted, rGBM, Robert, RTS®technology, salary, se, SEER, Senate, Serono, served, shifting, shipment, simply, situated, skinny, slate, stability, stealing, stereotactic, Stewart, stricter, struggled, subpopulation, suppressor, suspected, Symposia, synergistic, TACI, taxation, TBD, theJournal, Tmunity, Toca, top, transient, transmit, trend, tunable, underwritten, undetectable, Undisclosed, upregulated, USPTO, vaccine, variability, variable, vascular, vitroand, vitrotesting, Wafer, wait, welfare, Yescarta, young
Removed:
AaPC, aimed, alleviate, ANDA, began, billion, binomial, Bioethical, biology, book, caption, cavity, CEO, challenger, circulatory, coincide, College, combine, conference, construct, cut, developer, differentiated, dismal, disrupt, distant, district, divide, donor, earn, ECC, editing, efficiency, electroporation, enable, evergreening, exercised, exist, expedite, experimental, expired, explaining, expressing, facilitate, fashion, fast, filer, floor, furnished, harvested, Hutchinson, immunogenicity, immunological, immunostimulatory, indexed, inducible, industrialized, inherited, initiating, insert, installment, instrument, intensive, interchangeable, Jonathan, killing, launched, lawsuit, leukocyte, localized, lymph, lymphatic, men, metabolism, modulation, molecular, multigenic, Newer, Orange, ordered, organ, originate, outlined, pacific, paragraph, Pennsylvania, pharmacologic, pipeline, preceded, Presidential, propagate, PSHA, PTO, question, radiotherapy, Randall, redirect, relentlessly, reprogram, requested, requesting, retired, runaway, sarcoma, science, send, slightly, smoking, soft, SPA, specificity, stimulate, suit, supporting, surface, surrogate, synergy, technique, tenant, throughput, translate, unavailable, underwent, universal, unmet, vacated, validated, women, workforce, writing, yielded
Filing tables
Filing exhibits
Related press release
Associated TCRT transcripts
TCRT similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statements (Nos.333-129884,333-134280,333-142701,333-160496,333-167925,333-185433,333-199304 and333-220804) on FormsS-8 and Registration Statements (Nos.333-134279,333-141014,333-161453,333-162160,333-163517,333-166444,333-174292,333-177793, and333-201826) on FormsS-3 of our report dated March 1, 2018 relating to the financial statements and the effectiveness of internal control over financial reporting of ZIOPHARM Oncology, Inc., appearing in this Annual Report onForm 10-K of ZIOPHARM Oncology, Inc. for the year ended December 31, 2017.
/s/ RSM US LLP
Boston, Massachusetts
March 1, 2018